Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)
HKD 13.76
(-1.57%)
HKD 13.76
(-1.57%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.53 Billion CNY | 9.52% |
| 2022 | 6.88 Billion CNY | 25.77% |
| 2021 | 5.47 Billion CNY | 6.0% |
| 2020 | 5.16 Billion CNY | 31.02% |
| 2019 | 3.94 Billion CNY | 19.87% |
| 2018 | 3.28 Billion CNY | 19.52% |
| 2017 | 2.75 Billion CNY | 64.63% |
| 2016 | 1.67 Billion CNY | 1.33% |
| 2015 | 1.64 Billion CNY | 2.76% |
| 2014 | 1.6 Billion CNY | -0.6% |
| 2013 | 1.61 Billion CNY | 26.76% |
| 2012 | 1.27 Billion CNY | 13.3% |
| 2011 | 1.12 Billion CNY | 20.28% |
| 2010 | 934.41 Million CNY | 56.26% |
| 2009 | 597.99 Million CNY | 12.72% |
| 2008 | 530.52 Million CNY | 7.21% |
| 2007 | 494.84 Million CNY | -18.56% |
| 2006 | 607.58 Million CNY | 14.2% |
| 2005 | 532.04 Million CNY | 12.54% |
| 2004 | 472.75 Million CNY | 54.93% |
| 2003 | 305.13 Million CNY | -14.11% |
| 2002 | 355.25 Million CNY | 194.71% |
| 2001 | 120.54 Million CNY | 45.57% |
| 2000 | 82.8 Million CNY | -2.58% |
| 1999 | 85 Million CNY | 62.46% |
| 1998 | 52.32 Million CNY | 5.48% |
| 1997 | 49.6 Million CNY | 175.24% |
| 1996 | 18.02 Million CNY | 44.1% |
| 1995 | 12.5 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 7.29 Billion CNY | -3.22% |
| 2024 Q3 | 7.43 Billion CNY | -1.02% |
| 2024 Q2 | 7.51 Billion CNY | 2.97% |
| 2023 Q1 | 7.63 Billion CNY | 10.86% |
| 2023 Q2 | 7.86 Billion CNY | 3.1% |
| 2023 Q3 | 7.96 Billion CNY | 1.21% |
| 2023 Q4 | 7.53 Billion CNY | -5.33% |
| 2023 FY | 7.53 Billion CNY | 9.52% |
| 2022 Q1 | 5.62 Billion CNY | 2.74% |
| 2022 FY | 6.88 Billion CNY | 25.77% |
| 2022 Q4 | 6.88 Billion CNY | 1.62% |
| 2022 Q3 | 6.77 Billion CNY | 10.24% |
| 2022 Q2 | 6.14 Billion CNY | 9.28% |
| 2021 Q3 | 5.6 Billion CNY | 2.19% |
| 2021 Q4 | 5.47 Billion CNY | -2.38% |
| 2021 FY | 5.47 Billion CNY | 6.0% |
| 2021 Q1 | 5.17 Billion CNY | 0.25% |
| 2021 Q2 | 5.48 Billion CNY | 5.99% |
| 2020 Q1 | 4.15 Billion CNY | 5.39% |
| 2020 FY | 5.16 Billion CNY | 31.02% |
| 2020 Q2 | 4.56 Billion CNY | 9.84% |
| 2020 Q3 | 4.72 Billion CNY | 3.48% |
| 2020 Q4 | 5.16 Billion CNY | 9.37% |
| 2019 FY | 3.94 Billion CNY | 19.87% |
| 2019 Q1 | 3.54 Billion CNY | 7.69% |
| 2019 Q2 | 3.63 Billion CNY | 2.77% |
| 2019 Q3 | 3.85 Billion CNY | 6.06% |
| 2019 Q4 | 3.94 Billion CNY | 2.12% |
| 2018 Q3 | 3.04 Billion CNY | -1.59% |
| 2018 FY | 3.28 Billion CNY | 19.52% |
| 2018 Q2 | 3.08 Billion CNY | 4.59% |
| 2018 Q4 | 3.28 Billion CNY | 8.12% |
| 2018 Q1 | 2.95 Billion CNY | 7.4% |
| 2017 Q4 | 2.75 Billion CNY | 40.03% |
| 2017 FY | 2.75 Billion CNY | 64.63% |
| 2017 Q3 | 1.96 Billion CNY | -0.07% |
| 2017 Q2 | 1.96 Billion CNY | 10.65% |
| 2017 Q1 | 1.77 Billion CNY | 6.33% |
| 2016 Q2 | 1.69 Billion CNY | 7.33% |
| 2016 Q4 | 1.67 Billion CNY | 2.95% |
| 2016 FY | 1.67 Billion CNY | 1.33% |
| 2016 Q3 | 1.62 Billion CNY | -4.45% |
| 2016 Q1 | 1.58 Billion CNY | -4.02% |
| 2015 Q4 | 1.64 Billion CNY | 1.32% |
| 2015 Q2 | 1.63 Billion CNY | 0.8% |
| 2015 FY | 1.64 Billion CNY | 2.76% |
| 2015 Q3 | 1.62 Billion CNY | -0.77% |
| 2015 Q1 | 1.62 Billion CNY | 1.4% |
| 2014 Q2 | 1.78 Billion CNY | 5.65% |
| 2014 Q1 | 1.68 Billion CNY | 4.55% |
| 2014 Q4 | 1.6 Billion CNY | -9.21% |
| 2014 FY | 1.6 Billion CNY | -0.6% |
| 2014 Q3 | 1.76 Billion CNY | -0.88% |
| 2013 FY | 1.61 Billion CNY | 26.76% |
| 2013 Q4 | 1.61 Billion CNY | -0.93% |
| 2013 Q3 | 1.62 Billion CNY | 11.94% |
| 2013 Q2 | 1.45 Billion CNY | 18.13% |
| 2013 Q1 | 1.23 Billion CNY | -3.24% |
| 2012 Q4 | 1.27 Billion CNY | 3.58% |
| 2012 FY | 1.27 Billion CNY | 13.3% |
| 2012 Q1 | 1.16 Billion CNY | 3.45% |
| 2012 Q2 | 1.23 Billion CNY | 5.84% |
| 2012 Q3 | 1.22 Billion CNY | -0.09% |
| 2011 Q4 | 1.12 Billion CNY | 8.52% |
| 2011 Q1 | 942.12 Million CNY | 0.83% |
| 2011 Q2 | 929.47 Million CNY | -1.34% |
| 2011 FY | 1.12 Billion CNY | 20.28% |
| 2011 Q3 | 1.03 Billion CNY | 11.43% |
| 2010 FY | 934.41 Million CNY | 56.26% |
| 2010 Q1 | 563.02 Million CNY | -5.85% |
| 2010 Q3 | 657.12 Million CNY | 0.69% |
| 2010 Q4 | 934.41 Million CNY | 42.2% |
| 2010 Q2 | 652.61 Million CNY | 15.91% |
| 2009 Q1 | 542.48 Million CNY | 2.25% |
| 2009 Q4 | 597.99 Million CNY | 8.42% |
| 2009 Q3 | 551.56 Million CNY | 3.26% |
| 2009 FY | 597.99 Million CNY | 12.72% |
| 2009 Q2 | 534.16 Million CNY | -1.53% |
| 2008 Q3 | 521.59 Million CNY | -1.63% |
| 2008 Q4 | 530.52 Million CNY | 1.71% |
| 2008 Q1 | 518.3 Million CNY | 4.74% |
| 2008 FY | 530.52 Million CNY | 7.21% |
| 2008 Q2 | 530.25 Million CNY | 2.31% |
| 2007 Q3 | 488.84 Million CNY | -8.83% |
| 2007 Q2 | 536.17 Million CNY | 2.37% |
| 2007 FY | 494.84 Million CNY | -18.56% |
| 2007 Q1 | 523.73 Million CNY | -13.8% |
| 2007 Q4 | 494.84 Million CNY | 1.23% |
| 2006 Q2 | 528.54 Million CNY | 0.47% |
| 2006 Q4 | 607.58 Million CNY | 12.77% |
| 2006 Q3 | 538.78 Million CNY | 1.94% |
| 2006 Q1 | 526.08 Million CNY | -1.12% |
| 2006 FY | 607.58 Million CNY | 14.2% |
| 2005 Q3 | 488.51 Million CNY | -5.81% |
| 2005 Q4 | 532.04 Million CNY | 8.91% |
| 2005 Q1 | 490.23 Million CNY | 3.7% |
| 2005 Q2 | 518.64 Million CNY | 5.79% |
| 2005 FY | 532.04 Million CNY | 12.54% |
| 2004 Q3 | 373.25 Million CNY | -5.67% |
| 2004 Q1 | 305.94 Million CNY | 0.26% |
| 2004 Q2 | 395.68 Million CNY | 29.33% |
| 2004 FY | 472.75 Million CNY | 54.93% |
| 2004 Q4 | 472.75 Million CNY | 26.65% |
| 2003 Q3 | 303.59 Million CNY | -13.77% |
| 2003 Q1 | 321.78 Million CNY | -9.42% |
| 2003 Q4 | 305.13 Million CNY | 0.51% |
| 2003 Q2 | 352.07 Million CNY | 9.41% |
| 2003 FY | 305.13 Million CNY | -14.11% |
| 2002 Q1 | 113.87 Million CNY | -5.53% |
| 2002 FY | 355.25 Million CNY | 194.71% |
| 2002 Q3 | 139.74 Million CNY | -3.04% |
| 2002 Q2 | 144.13 Million CNY | 26.57% |
| 2002 Q4 | 355.25 Million CNY | 154.22% |
| 2001 Q4 | 120.54 Million CNY | 0.0% |
| 2001 FY | 120.54 Million CNY | 45.57% |
| 2001 Q2 | 112.82 Million CNY | 0.0% |
| 2000 FY | 82.8 Million CNY | -2.58% |
| 2000 Q2 | 90.8 Million CNY | 0.0% |
| 2000 Q4 | 82.8 Million CNY | 0.0% |
| 1999 Q2 | 61.94 Million CNY | 0.0% |
| 1999 Q4 | 85 Million CNY | 0.0% |
| 1999 FY | 85 Million CNY | 62.46% |
| 1998 FY | 52.32 Million CNY | 5.48% |
| 1998 Q4 | 52.32 Million CNY | 0.0% |
| 1998 Q2 | 7.88 Million CNY | 0.0% |
| 1997 FY | 49.6 Million CNY | 175.24% |
| 1996 FY | 18.02 Million CNY | 44.1% |
| 1995 FY | 12.5 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -61700.184% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | -442.813% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -103654.546% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -2346.549% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -1645.718% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -2428.553% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -11898.627% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -7570.779% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -4192.652% |
| SSY Group Limited | 1.08 Billion HKD | -593.905% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -8130.352% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -2271.434% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 78.522% |